133 related articles for article (PubMed ID: 6601707)
1. Effects of particulate beta-1,3 glucan on human, rat, and guinea pig complement activity.
Glovsky MM; Cortes-Haendchen L; Ghekiere L; Alenty A; Williams DL; Di Luzio R
J Reticuloendothel Soc; 1983 May; 33(5):401-13. PubMed ID: 6601707
[TBL] [Abstract][Full Text] [Related]
2. Properties of glycans that activate the human alternative complement pathway and interact with the human monocyte beta-glucan receptor.
Czop JK; Austen KF
J Immunol; 1985 Nov; 135(5):3388-93. PubMed ID: 4045195
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the classical and alternate complement pathway with endotoxin lipopolysaccharide. Effect on platelets and blood coagulation.
Kane MA; May JE; Frank MM
J Clin Invest; 1973 Feb; 52(2):370-6. PubMed ID: 4683877
[TBL] [Abstract][Full Text] [Related]
4. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
[TBL] [Abstract][Full Text] [Related]
5. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
[TBL] [Abstract][Full Text] [Related]
6. IgG and complement-mediated tissue damage in the absence of C2: evidence of a functionally active C2-bypass pathway in a guinea pig model.
Wagner E; Platt JL; Howell DN; Marsh HC; Frank MM
J Immunol; 1999 Sep; 163(6):3549-58. PubMed ID: 10477630
[TBL] [Abstract][Full Text] [Related]
7. Complement activating property of the protein-rich endotoxin (OEP) of Pseudomonas aeruginosa. I. Activation of both the classical and the alternative pathways of guinea pig complement.
Inada K
Jpn J Exp Med; 1980 Feb; 50(1):13-21. PubMed ID: 6770130
[TBL] [Abstract][Full Text] [Related]
8. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
9. A beta-glucan inhibitable receptor on human monocytes: its identity with the phagocytic receptor for particulate activators of the alternative complement pathway.
Czop JK; Austen KF
J Immunol; 1985 Apr; 134(4):2588-93. PubMed ID: 2579146
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis of particulate activators of the human alternative complement pathway through monocyte beta-glucan receptors.
Czop JK; Valiante NM; Janusz MJ
Prog Clin Biol Res; 1989; 297():287-96. PubMed ID: 2555820
[TBL] [Abstract][Full Text] [Related]
11. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
Miyama A; Kato T; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
[TBL] [Abstract][Full Text] [Related]
12. Mobilization of hematopoietic progenitor cells by yeast-derived beta-glucan requires activation of matrix metalloproteinase-9.
Cramer DE; Wagner S; Li B; Liu J; Hansen R; Reca R; Wu W; Surma EZ; Laber DA; Ratajczak MZ; Yan J
Stem Cells; 2008 May; 26(5):1231-40. PubMed ID: 18339771
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effect of various antisera and cobra venom factor on inflammatory reactions in guinea-pig skin. I. Non-specific inflammation due to the intradermal injection of turpentine.
Lewis E; Turk JL
J Pathol; 1975 Feb; 115(2):97-109. PubMed ID: 1080193
[TBL] [Abstract][Full Text] [Related]
14. Modulatory effect of glucans on the functional and biochemical activities of guinea-pig macrophages.
Ferencík M; Kotulová D; Masler L; Bergendi L; Sandula J; Stefanovic J
Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):163-6. PubMed ID: 3012227
[TBL] [Abstract][Full Text] [Related]
15. Influence of a bagasse glucan (B0) on leukocyte aggregation and accumulation.
Li XY; Damerau B; Vogt W
Zhongguo Yao Li Xue Bao; 1985 Jun; 6(2):137-40. PubMed ID: 2934950
[No Abstract] [Full Text] [Related]
16. Heparin and derivatized heparin inhibit zymosan and cobra venom factor activation of complement in serum.
Edens RE; Linhardt RJ; Bell CS; Weiler JM
Immunopharmacology; 1994; 27(2):145-53. PubMed ID: 8014028
[TBL] [Abstract][Full Text] [Related]
17. Pathway-specific complement activity in pigs evaluated with a human functional complement assay.
Salvesen B; Mollnes TE
Mol Immunol; 2009 May; 46(8-9):1620-5. PubMed ID: 19328551
[TBL] [Abstract][Full Text] [Related]
18. Activation of first component of complement (C1) in guinea pig serum by a polysaccharide is prevented by C1 inhibitor.
Schultz DR; Arnold PI
J Immunol; 1981 Apr; 126(4):1558-61. PubMed ID: 7204976
[TBL] [Abstract][Full Text] [Related]
19. Role of the complement system in antigen-induced bronchoconstriction and changes in blood pressure in the guinea pig.
Regal JF; Fraser DG; Toth CA
J Pharmacol Exp Ther; 1993 Nov; 267(2):979-88. PubMed ID: 8246173
[TBL] [Abstract][Full Text] [Related]
20. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
Cheung NK; Modak S
Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
